In 1990, nearly 1.5 million human immunodeficiency virus (HIV) antibody tests were performed at publicly funded sites.
Eight percent of those tests were performed for self-identified illegal injecting drug users (IDU).
The authors examined data from 28 project areas using a client record data base that permitted an analysis of self-reported risk behavior by type of service delivery site.
Among self-identified IDUs, 68 percent of those tested and 82 percent of those found to be seropositive had obtained HIV counseling and testing services in settings other than drug treatment centers.
The findings indicate that HIV-prevention programs for IDUs need to be available in various service delivery settings, not just in drug treatment programs.
Mots-clés Pascal : Toxicomanie, Immunodéficit acquis syndrome, Virose, Infection, Service santé, Voie intraveineuse, Homme, Hémopathie, Immunopathologie, Dépistage, Conseil psychologique, Prévention, Secteur public, Organisation santé, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Drug addiction, AIDS, Viral disease, Infection, Health service, Intravenous administration, Human, Hemopathy, Immunopathology, Medical screening, Psychological counseling, Prevention, Public sector, Public health organization, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 93-0499060
Code Inist : 002B30A03A. Création : 199406.